Elite Pharmaceuticals, Inc. Common Stock (ELTP) Stock Price & News

Why is ELTP up 32.61%?

Dive Deeper

ELTP:OTCMKTS

Elite Pharmaceuticals, Inc. Common Stock

$0.32

+32.61%

(+0.080) 1D

Nov 13, 4:00:00 PM GMT-5 · USD

All symbols

	Symbol	Price	Change	% Change

Generating top insights for ELTP...

Open

$0.25

High

$0.35

Low

$0.24

Mkt. cap

350.10M

Avg. vol.

669.04K

Volume

4.63M

P/E ratio

6.62

52-wk high

$0.68

52-wk low

$0.21

EPS

$0.05

Beta

0.44

Shares outstanding

1.08B

No. of employees

Open

$0.25

High

$0.35

Low

$0.24

Mkt. cap

350.10M

Avg. vol.

669.04K

Volume

4.63M

P/E ratio

6.62

52-wk high

$0.68

52-wk low

$0.21

EPS

$0.05

Beta

0.44

Shares outstanding

1.08B

No. of employees

Related stocks

Palantir Technologies Inc

$167.99

-2.09%

NWBO

Northwest Biotherapeutics Inc

$0.16

-5.21%

News stories

From web sources and news partners

GuruFocus

1 day ago

Elite Pharmaceuticals (ELTP) Reports Q2 Fiscal 2027 Earnings Hig

TradingView

1 day ago

What Elite Pharmaceuticals (ELTP) Said on Its Q2 Earnings Call

Investing.com

1 day ago

Earnings call transcript: Elite Pharmaceuticals Q2 2027 revenue rises 10% as stock jumps

Yahoo! Finance Canada

2 days ago

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2027 ended September 30, 2026 and Provides Conference Call Information

About Elite Pharmaceuticals, Inc. Common Stock

CEO-

Employees65

Founded1997

HeadquartersNorthvale, New Jersey, United States

SectorHealth Care

IndustryPharmaceutical industry

Websiteelitepharma.com

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	36.32M	31.59M	40.75M	32.36M
Cost of goods sold	22.25M	18.64M	19.98M	18.85M
Cost of revenue	22.25M	18.64M	19.98M	18.85M
Research and development expenses	1.39M	1.04M	1.64M	2.03M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	4.03M	2.47M	7.70M	3.55M
Operating expense	5.86M	3.94M	9.74M	5.98M
Total operating expenses	28.11M	22.58M	29.71M	24.83M
Operating income	8.21M	9.01M	11.03M	7.53M
Other non operating income	7.55M	11.82M	10.63M	94.25K
EBT including unusual items	15.69M	20.83M	20.85M	7.72M
EBT excluding unusual items	15.69M	20.83M	21.70M	7.72M
Income tax expense	1.99M	2.24M	2.39M	1.81M
Effective tax rate	12.67%	10.75%	11.48%	23.40%
Other operating expenses	-	-	-	-
Net income	13.70M	18.59M	18.46M	5.91M
Net profit margin	37.73%	58.86%	45.31%	18.27%
Earnings per share	-	-	-	-
Interest and investment income	4.92K	83.60K	114.79K	166.12K
Interest expense	-82.47K	-80.20K	-75.06K	-73.10K
Net interest expenses	-77.55K	3.40K	39.73K	93.01K
Depreciation and amortization charges	394.86K	388.14K	369.99K	367.76K
EBITDA	8.61M	9.40M	11.40M	7.90M
Gain or loss from assets sale	-	-	-	-

Ask anything